Raymond J. Henley Iii

Array ( [id] => 6653414 [patent_doc_number] => 20030008892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Pharmaceutical composition and method of modulating cholinergic function in a mammal' [patent_app_type] => new [patent_app_number] => 10/105605 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11976 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008892.pdf [firstpage_image] =>[orig_patent_app_number] => 10105605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538431 [patent_doc_number] => 20020193435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Nitroglycerin-menthol potentiation for treatment of angina' [patent_app_type] => new [patent_app_number] => 10/104132 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1537 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193435.pdf [firstpage_image] =>[orig_patent_app_number] => 10104132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1327890 [patent_doc_number] => 06599897 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Quetiapine granules' [patent_app_type] => B1 [patent_app_number] => 10/088804 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3456 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599897.pdf [firstpage_image] =>[orig_patent_app_number] => 10088804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796485 [patent_doc_number] => 20030175359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'EGG HAVING ACTIVE OXYGEN ELIMINATING ABILITY AND METHOD OF PRODUCING SAME' [patent_app_type] => new [patent_app_number] => 10/096291 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2730 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175359.pdf [firstpage_image] =>[orig_patent_app_number] => 10096291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312729 [patent_doc_number] => 06610652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Microdose therapy' [patent_app_type] => B2 [patent_app_number] => 10/095654 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 10777 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610652.pdf [firstpage_image] =>[orig_patent_app_number] => 10095654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658249 [patent_doc_number] => 20030078269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus' [patent_app_type] => new [patent_app_number] => 10/093476 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30867 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078269.pdf [firstpage_image] =>[orig_patent_app_number] => 10093476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651678 [patent_doc_number] => 20030105091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/086417 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29322 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105091.pdf [firstpage_image] =>[orig_patent_app_number] => 10086417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 380123 [patent_doc_number] => 07309698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-18 [patent_title] => 'Compositions for delivering bisphosphonates' [patent_app_type] => utility [patent_app_number] => 10/468622 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7022 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309698.pdf [firstpage_image] =>[orig_patent_app_number] => 10468622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569513 [patent_doc_number] => 20020165272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PSYCHOTIC DISORDERS' [patent_app_type] => new [patent_app_number] => 10/081761 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5770 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165272.pdf [firstpage_image] =>[orig_patent_app_number] => 10081761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6330191 [patent_doc_number] => 20020198257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING BIPOLAR DISORDER' [patent_app_type] => new [patent_app_number] => 10/081766 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4469 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198257.pdf [firstpage_image] =>[orig_patent_app_number] => 10081766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699480 [patent_doc_number] => 07067557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Methods of treating androgen deficiency in men using selective antiestrogens' [patent_app_type] => utility [patent_app_number] => 10/081098 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1541 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067557.pdf [firstpage_image] =>[orig_patent_app_number] => 10081098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6156774 [patent_doc_number] => 20020146424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Polyphenolics for enhancing endothelial cell-mediated fibrinolysis' [patent_app_type] => new [patent_app_number] => 10/078267 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4098 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146424.pdf [firstpage_image] =>[orig_patent_app_number] => 10078267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569099 [patent_doc_number] => 20020165247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'USE OF MORPHINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF NEUROPATHIC PROBLEMS' [patent_app_type] => new [patent_app_number] => 10/076109 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4550 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165247.pdf [firstpage_image] =>[orig_patent_app_number] => 10076109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337554 [patent_doc_number] => 20040132829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria' [patent_app_type] => new [patent_app_number] => 10/468138 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4938 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132829.pdf [firstpage_image] =>[orig_patent_app_number] => 10468138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474671 [patent_doc_number] => 20020151576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Method and compositions for reducing cardiac dysfunctions with a selective histamine H3 receptor agonist' [patent_app_type] => new [patent_app_number] => 10/076204 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8829 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151576.pdf [firstpage_image] =>[orig_patent_app_number] => 10076204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1307755 [patent_doc_number] => 06617359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-09 [patent_title] => '4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical' [patent_app_type] => B2 [patent_app_number] => 10/073330 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4323 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617359.pdf [firstpage_image] =>[orig_patent_app_number] => 10073330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159161 [patent_doc_number] => 20020147228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'AGENT FOR HYPOALBUMINAEMIA' [patent_app_type] => new [patent_app_number] => 10/074772 [patent_app_country] => US [patent_app_date] => 2002-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4257 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147228.pdf [firstpage_image] =>[orig_patent_app_number] => 10074772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404228 [patent_doc_number] => 06534500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-18 [patent_title] => 'Use of cyamemazine in the treatment of abrupt benzodiazephine withdrawal' [patent_app_type] => B2 [patent_app_number] => 10/073436 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1773 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534500.pdf [firstpage_image] =>[orig_patent_app_number] => 10073436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367939 [patent_doc_number] => 20040092523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Method for the treatment of heart failure' [patent_app_type] => new [patent_app_number] => 10/467459 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2696 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092523.pdf [firstpage_image] =>[orig_patent_app_number] => 10467459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1115597 [patent_doc_number] => RE038604 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-09-28 [patent_title] => 'Fluid therapy with L-lactate and/or pyruvate anions' [patent_app_type] => E1 [patent_app_number] => 10/060169 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5735 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038604.pdf [firstpage_image] =>[orig_patent_app_number] => 10060169 [rel_patent_id] =>[rel_patent_doc_number] =>)